Insider Stock Trading History of Sullivan Louis W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sullivan Louis W since year 2005. The trader's CIK number is 1193522. At the time of this reporting, Sullivan Louis W is the Director of United Therapeutics Corp . (stock ticker symbol UTHR). See this page for all insider trading activities at United Therapeutics Corp .

Note that in the past SULLIVAN LOUIS W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sullivan Louis W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-21 UTHR United Therapeutics Corp Option Ex 1,750 .00 0
2016-03-11 EBS Emergent Biosolutions Inc. Option Ex 14,879 10.28 152,956
2016-03-11 EBS Emergent Biosolutions Inc. Sale 14,879 34.03 506,332
2016-03-10 EBS Emergent Biosolutions Inc. Option Ex 14,820 10.28 152,349
2016-03-10 EBS Emergent Biosolutions Inc. Sale 14,820 35.34 523,738
2015-11-17 HSIC Schein Henry Inc Sale 15,622 154.24 2,409,459
2015-11-17 HSIC Schein Henry Inc Option Ex 13,677 49.27 673,865
2015-06-18 UTHR United Therapeutics Corp Option Ex 45,000 35.95 1,617,525
2015-06-18 UTHR United Therapeutics Corp Sale 15,000 185.60 2,783,970
2015-06-16 EBS Emergent Biosolutions Inc. Sale 13,457 31.32 421,540
2015-06-16 EBS Emergent Biosolutions Inc. Option Ex 13,457 10.28 138,337
2014-08-29 HSIC Schein Henry Inc Sale 17,262 120.11 2,073,425
2014-08-29 HSIC Schein Henry Inc Option Ex 13,862 39.43 546,578
2014-05-22 UTHR United Therapeutics Corp Option Ex 30,000 31.17 935,100
2014-05-22 UTHR United Therapeutics Corp Sale 30,000 101.28 3,038,460
2014-05-13 HSIC Schein Henry Inc Sale 1,638 116.00 189,999
2014-05-13 HSIC Schein Henry Inc Option Ex 1,638 43.37 71,040
2013-09-30 UTHR United Therapeutics Corp Option Ex 42,000 26.05 1,093,890
2013-09-30 UTHR United Therapeutics Corp Sale 42,000 78.48 3,296,118
2013-08-20 HSIC Schein Henry Inc Option Ex 15,000 35.49 532,350
2013-08-20 HSIC Schein Henry Inc Sale 15,000 103.91 1,558,650
2011-08-15 BPAX Biosante Pharmaceuticals Inc Buy 10,000 2.67 26,700
2011-05-02 UTHR United Therapeutics Corp Option Ex 6,000 24.39 146,340
2011-05-02 UTHR United Therapeutics Corp Sale 6,000 66.96 401,759
2011-03-15 HSIC Schein Henry Inc Option Ex 19,500 21.70 423,150
2011-03-15 HSIC Schein Henry Inc Sale 19,500 65.60 1,279,200
2011-03-01 UTHR United Therapeutics Corp Sale 6,000 67.39 404,328
2011-03-01 UTHR United Therapeutics Corp Option Ex 6,000 24.39 146,340
2011-01-13 BPAX Biosante Pharmaceuticals Inc Buy 10,000 1.72 17,200
2011-01-03 UTHR United Therapeutics Corp Sale 6,000 63.93 383,592
2011-01-03 UTHR United Therapeutics Corp Option Ex 6,000 24.39 146,340
2010-10-28 UTHR United Therapeutics Corp Option Ex 400 22.57 9,026
2010-10-29 UTHR United Therapeutics Corp Option Ex 5,600 22.57 126,364
2010-10-28 UTHR United Therapeutics Corp Sale 400 60.00 24,000
2010-10-29 UTHR United Therapeutics Corp Sale 5,600 60.00 336,000
2010-08-12 UTHR United Therapeutics Corp Sale 24,000 50.50 1,212,024
2010-08-12 UTHR United Therapeutics Corp Option Ex 24,000 12.64 303,360
2010-08-09 UTHR United Therapeutics Corp Option Ex 1,282 11.63 14,916
2010-08-09 UTHR United Therapeutics Corp Sale 1,282 51.85 66,471
2007-12-11 UTHR United Therapeutics Corp Option Ex 20,213 19.79 399,914
2007-12-11 UTHR United Therapeutics Corp Sale 20,213 105.29 2,128,267

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sullivan Louis W (Director of United Therapeutics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.